2021
DOI: 10.1007/s10238-021-00721-z
|View full text |Cite|
|
Sign up to set email alerts
|

RETRACTED ARTICLE: Long non-coding RNA PICSAR serves as a non-invasive biomarker for the diagnosis and prognosis of cutaneous squamous cell carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 42 publications
0
1
0
Order By: Relevance
“…Different lncRNAs have been found to be overexpressed in various tumors, hence they could be used as novel targets or biomarkers for the diagnosis and treatment of CSCC. For example, lncRNA PICSAR is upregulated in CSCC tumors and can be used as a noninvasive biomarker for the diagnosis and prognosis of CSCC patients [17]. In addition, the upregulation of LINC00319 expression is strongly linked to poor prognosis in CSCC patients, providing some evidence as an alternative target for CSCC therapy [18].…”
Section: Discussionmentioning
confidence: 99%
“…Different lncRNAs have been found to be overexpressed in various tumors, hence they could be used as novel targets or biomarkers for the diagnosis and treatment of CSCC. For example, lncRNA PICSAR is upregulated in CSCC tumors and can be used as a noninvasive biomarker for the diagnosis and prognosis of CSCC patients [17]. In addition, the upregulation of LINC00319 expression is strongly linked to poor prognosis in CSCC patients, providing some evidence as an alternative target for CSCC therapy [18].…”
Section: Discussionmentioning
confidence: 99%